143 related articles for article (PubMed ID: 31200818)
1. Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.
Tsim S; Paterson S; Cartwright D; Fong CJ; Alexander L; Kelly C; Holme J; Evison M; Blyth KG
Lung Cancer; 2019 Jul; 133():123-129. PubMed ID: 31200818
[TBL] [Abstract][Full Text] [Related]
2. Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.
Tsim S; Humphreys CA; Cowell GW; Stobo DB; Noble C; Woodward R; Kelly CA; Alexander L; Foster JE; Dick C; Blyth KG
Lung Cancer; 2018 Apr; 118():48-56. PubMed ID: 29572002
[TBL] [Abstract][Full Text] [Related]
3. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
4. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
[TBL] [Abstract][Full Text] [Related]
5. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
Paintal A; Raparia K; Zakowski MF; Nayar R
Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.
Fortin M; Cabon E; Berbis J; Laroumagne S; Guinde J; Elharrar X; Dutau H; Astoul P
Respiration; 2020; 99(1):28-34. PubMed ID: 31655816
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of medical thoracoscopy in malignant pleural effusion.
Wu YB; Xu LL; Wang XJ; Wang Z; Zhang J; Tong ZH; Shi HZ
BMC Pulm Med; 2017 Aug; 17(1):109. PubMed ID: 28778184
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.
Okten F; Köksal D; Onal M; Ozcan A; Simşek C; Ertürk H
Clin Imaging; 2006; 30(3):177-80. PubMed ID: 16632152
[TBL] [Abstract][Full Text] [Related]
11. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study.
Pairman L; Beckert LEL; Dagger M; Maze MJ
Intern Med J; 2022 Jul; 52(7):1154-1159. PubMed ID: 35191191
[TBL] [Abstract][Full Text] [Related]
13. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
15. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
16. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.
Ferrer J; Roldán J; Teixidor J; Pallisa E; Gich I; Morell F
Chest; 2005 Mar; 127(3):1017-22. PubMed ID: 15764788
[TBL] [Abstract][Full Text] [Related]
17. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
Kassirian S; Hinton SN; Cuninghame S; Chaudhary R; Iansavitchene A; Amjadi K; Dhaliwal I; Zeman-Pocrnich C; Mitchell MA
Thorax; 2023 Jan; 78(1):32-40. PubMed ID: 35110369
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
20. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
Maskell NA; Gleeson FV; Davies RJ
Lancet; 2003 Apr; 361(9366):1326-30. PubMed ID: 12711467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]